The drop-off was even higher among those without type 2 diabetes: 85 percent quit after two years
It's a waste issue
This guide explains the reactions reported in clinical research, including nausea, diarrhea, vomiting, constipation, fatigue, appetite changes, and injection-site discomfort
They also have a life expectancy of 79.1 years, are significantly less likely to attend routine health screenings, are more likely to delay seeking medical attention for concerning symptoms, and face higher rates of cardiovascular disease, type 2 diabetes, liver disease, and suicide
While Retatrutide is unavailable today, it's expected to launch post-FDA approval, tentatively projected for 2028 following ongoing trials
Unreconstituted lyophilised IGF-1 LR3 powder remains stable for 2436 months when stored at 20C, with minimal degradation occurring under continuous frozen conditions